
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical's stock outlook is bolstered by significant year-over-year growth in procedure volumes, with a notable 13% increase that was further enhanced to 14% in the US, particularly within General Surgery. The company is experiencing strong utilization growth across its Ion and SP systems, with Ion utilization up 11% and SP utilization increasing by 21%, contributing to an expanding installed base and higher average selling prices for systems. Additionally, the sharp acceleration in anticipated metrics from FY24 to FY25 indicates successful expansion into new surgical specialties, strengthening Intuitive Surgical's market position and future growth potential.
Bears say
The financial analysis indicates a negative outlook for Intuitive Surgical's stock due to anticipated downward pressure on average selling prices (ASPs) for both systems and instrumentation and accessories, stemming from a decrease in bariatric procedure volumes. Despite initial expectations for growth linked to the Dv5 system launch, concerns arise from the realization that system growth is primarily driven by Dv5 adoption, while instrumentation and accessories growth remains weakly correlated to this growth. Additionally, slower-than-expected capital placements and overall utilization levels, particularly in Japan and specific surgical procedures, suggest challenges in maintaining robust growth across the company's operations.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares